# Agios Pharmaceuticals, Inc.: Form 8-K, filed Jan 6, 2025

- Company: [Agios Pharmaceuticals, Inc.](/companies/agio.md) (CIK 1439222)
- Form: 8-K
- Filed: 2025-01-06
- Accepted by EDGAR: Jan 6, 2025, 06:36 ET
- Period: 2025-01-03
- Accession: 0001193125-25-001809
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1439222/000119312525001809/d911895d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1439222/000119312525001809/

## Items reported

- Item 7.01: Regulation FD disclosure

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1439222/000119312525001809/d911895d8k.htm

Filed Jan 6, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-001809. Last ingested by Listed: Nov 5, 2026, 12:45 ET. No prices; not investment advice.